# Beta Blockade in in Traumatic Brain Injury

> **NCT02957331** · PHASE4 · COMPLETED · sponsor: **University of Tennessee** · enrollment: 26 (actual)

## Conditions studied

- Brain Injuries, Traumatic

## Interventions

- **DRUG:** Propranolol

## Key facts

- **NCT ID:** NCT02957331
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2020-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02957331

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02957331, "Beta Blockade in in Traumatic Brain Injury". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02957331. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
